Bertred 3,5


Lyophilised powder for solution for injection: Vial
scheduling status
S4
registration number
51/26/0714
What Bertred 3,5 contains
Bortezomib (as a mannitol boronic ester).
other ingredients
Mannitol Nitrogen Tertiary butanol Water for injection.
Therapeutic classification
A 26 Cytostatic agents.
© 2026 SAHPRA. ALL RIGHTS RESERVED